• News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Digital edition
    • Archived issues
    • Media kit
    • Submit Press Release
  • White Papers
  • Events
  • Suppliers
  • E-Alert
  • Contact us
  • FREE newsletter subscription
  • Search
  • Menu Menu
International Hospital
  • AI
  • Cardiology
  • Oncology
  • Neurology
  • Genetics
  • Orthopaedics
  • Research
  • Surgery
  • Innovation
  • Medical Imaging
  • MedTech
  • Obs-Gyn
  • Paediatrics

Archive for category: E-News

E-News

Implanted cardiac monitors indicate incidence of undiagnosed AFib may be substantial in high-risk patients

, 26 August 2020/in E-News /by 3wmedia

With the use of implanted cardiac monitors researchers found a substantial incidence (nearly 30 percent) of previously undiagnosed atrial fibrillation (AF) after 18 months in patients at high risk of both AF and stroke, according to a study.
Atrial fibrillation affects millions of people worldwide and increases with older age, hypertension, diabetes, and heart failure, conditions that are associated with increased stroke risk. Atrial fibrillation episodes may be symptomatic, asymptomatic (i.e., silent AF), or both. Heart failure or stroke can be the first clinical manifestation of AF. Recognition of previously undiagnosed AF and initiation of appropriate therapies is essential for stroke prevention.
Minimally invasive prolonged electrocardiographic monitoring with small, insertable cardiac monitors (ICMs) placed under the skin could assist with early AF diagnosis and earlier treatment. James A. Reiffel, M.D., of the Columbia University College of Physicians and Surgeons, New York, and colleagues conducted a study in which 385 patients received an insertable cardiac monitor. The patients were at high risk of both AF and stroke; approximately 90 percent had nonspecific symptoms potentially compatible with AF, such as fatigue, breathing difficulties, and/or palpitations, and had either three or more of heart failure, hypertension, age 75 or older, diabetes, prior stroke or transient ischemic attack (TIA), or two of the former plus at least one of the following additional AF risk factors: coronary artery disease, renal impairment, sleep apnea, or chronic obstructive pulmonary disease. Patients underwent monitoring for 18 to 30 months.
The researchers found that the detection rate of AF lasting six or more minutes at 18 months was 29 percent. Detection rates at 30 days and 6, 12, 24, and 30 months were 6 percent, 20 percent, 27 percent, 34 percent, and 40 percent, respectively. Median time from device insertion to first AF episode detection was 123 days. Of patients with AF lasting six or more minutes at 18 months, 10 percent had one or more episodes lasting 24 hours or longer, and oral anticoagulation therapy was prescribed for 72 patients (56 percent).
The study notes some limitations, including its modest size.
The authors write that as the AF incidence was still rising at 30 months, the ideal monitoring duration is unclear. "Further trials regarding the value of detecting subclinical AF and of prophylactic therapies are warranted."

ScienceDaily www.sciencedaily.com/releases/2017/08/170827101755.htm

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:36:442020-08-26 14:37:05Implanted cardiac monitors indicate incidence of undiagnosed AFib may be substantial in high-risk patients

Promising results for patients with endoscopic treatments

, 26 August 2020/in E-News /by 3wmedia

Simpler, easier method for performing biopsy can improve patient care
A simpler biopsy procedure than the one traditionally used can give equally good results while reducing stress for patients and workers, and allowing for faster diagnosis, according to a study.
During various procedures performed by gastrointestinal endoscopists, small tissue samples are taken from the patient for examination, which is known as biopsy. The traditional endoscopic forceps biopsy method can be labour intensive as well as stressful for the workplace environment.
With this method, each specimen is removed and placed in fixative vial for identification. This is labour intensive, adding to the length of the procedure and the time under sedation. Biopsy samples from each site are filtered to remove fixative, inspected to record specimen number and size, and transferred to a container to undergo several more processing steps before being mounted on slides to be examined for abnormalities or disease.
According to the study authors, diagnosis is delayed by this complex and costly protocol. In addition, staff may be affected by ergonomic stress and workplace risk from exposure to sharps, toxic fixative, infectious material, and soil.
The researchers aimed to test a faster way of collecting, handling and processing the samples to slides through a method called endoscopic multiple biopsy (MB).
MB uses a single endoscope pass within the patient to obtain up to 25 biopsy specimens during withdrawal of the endoscope. These are collected and stored in a plastic chamber inside the removable metal tip of the endoscope. After completing the biopsy series, the metal tip is cut off, immersed in fixative, and sent to pathology. There, the plastic storage chamber’s design supports rapid logging of specimens, diagnosis by frozen section and microwave (one hour) or routine paraffin processing (four to six hours) of the specimen tissue.
For the study, biopsies were performed during colonoscopy, upper GI endoscopy, and endoscopic retrograde cholangiopancreatography (ERCP). The blinded retrospective study compared 125 colon surveillance biopsies in 15 patients who underwent MB with 15 patients who underwent forceps biopsies performed on the same day.
The researchers found that the processed MB specimens were not significantly different from batched processed forceps biopsy specimens for depth, orientation (done manually), fixation, artifacts, and diagnostic information. Multiple biopsy colonic specimens were significantly (26%) smaller but had better epithelial (cellular covering) preservation than forceps specimens. Each biopsy saves 61 seconds during withdrawal.
The authors concluded that single-pass MB reduces biopsy time with less specimen damage, work, workplace risk, and soiling. Diagnostic quality is equal to forceps biopsy with better cellular preservation, although 26% smaller. In pathology, the plastic chamber reduces work and workplace risk. MB speeds diagnosis and improves productivity in endoscopic biopsy and histopathologic processing (microscopic examination of biopsy samples for signs of or disease). They encourage larger studies at multiple centers to determine the value of MB for diagnosing a larger set of GI diseases.

American Society for Gastrointestinal Endoscopy
www.asge.org/home/about-asge/newsroom/news-list/2017/08/04/august-gie-studies-show-promising-results-for-patients-with-endoscopic-treatments

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:36:442020-08-26 14:37:09Promising results for patients with endoscopic treatments

Cancer imaging aid from horse chestnuts

, 26 August 2020/in E-News /by 3wmedia

Research at The City College of New York shows that cancer imaging can be simplified by a photonic process utilizing molecules derived from horse chestnuts. The study with potential to better detect the presence of cancer is led by George John, professor in City College’s Division of Science, in collaboration with Jan Grimm, a physician scientist at   Sloan Kettering Institute who is also affiliated with Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College.
The team has developed a radiation-responsive, esculin-derived molecular gel, that is both scintillating and fluorescent, to enhance the optical photon output in image mapping for cancer imaging.
Esculin is a coumarin glucoside that naturally occurs in the horse chestnut, a plant extract. It is beneficial to circulatory health.
A challenge currently in cancer imaging is that optical imaging of radiotracers through Cerenkov light (the Grimm lab is one of the leading labs in this field) often produces light that is typically low in intensity and blue-weighted (greatly scattered and absorbed in vivo). It is therefore imperative to increase or shift the photon flux for improved detection.
 The gel has been developed to address this challenge.
“Tailoring biobased materials to synthesize thixotropic thermo-reversible hydrogels offers image-aiding systems which are not only functional but also potentially economical, safe, and environmentally friendly,” said John.
“The possibility of developing a topical application from the gel makes this innovation an attractive potential improvement to current techniques of cancer imaging with Cerenkov light,” added Grimm.
John’s research is rooted in the idea that innovation can be inspired by nature to develop economical and green technologies for a sustainable future.
The City College of New Yorkhttps://tinyurl.com/y8jw969k

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:36:442020-08-26 14:36:45Cancer imaging aid from horse chestnuts

Doctors need cultural training

, 26 August 2020/in E-News /by 3wmedia

A study conducted at the Department of Global Public Health and Primary Care (IGS), University of Bergen (UiB), concluded that Norwegian family doctors show little cultural competency when dealing with patients from an immigrant background.
“We need a new strategy on immigrant health, which should include an obligatory component in medical training in cultural competency,” says Associate Professor Esperanza Diaz, at IGS. She is co-author on the study.
The researchers studied a group of general practitioners that were either training to become specialists or were already specialists. The study participants were asked questions about what kind of strategies they used in meetings with patients from immigrant backgrounds.
The doctors responded that they treated these patients similarly to patients without immigrant backgrounds. In follow-up discussions, the participating doctors recognised that they had experienced cultural differences between the different patient groups.
“We discovered that the Norwegian doctors engage in relatively little reflection about cultural differences and the potential impact of such differences. It is as though they think they, themselves, represent the normal zero point, and this concerns us,” Diaz says.
Diaz underlines that cultural competency should be a  part of the medical education curriculum.
“Today, cultural competency depends on medical students taking personal initiatives, such as by joining special courses or engaging in voluntary activities. Cultural competency should be part of the ordinary medical education curriculum,” says Esperanza Diaz.
University of Bergen
www.uib.no/en/med/111669/doctors-need-cultural-training

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:36:442020-08-26 14:36:50Doctors need cultural training

New approach uses ultrasound to measure fluid in the lungs

, 26 August 2020/in E-News /by 3wmedia

A team of engineering and medical researchers has found a way to use ultrasound to monitor fluid levels in the lung, offering a non-invasive way to track progress in treating pulmonary edema – fluid in the lungs – which often occurs in patients with congestive heart failure. The approach, which has been demonstrated in rats, also holds promise for diagnosing scarring, or fibrosis, in the lung.
“Historically, it has been difficult to use ultrasound to collect quantitative information on the lung, because ultrasound waves don’t travel through air– and the lung is full of air,” says Marie Muller, an assistant professor of mechanical engineering at North Carolina State University and co-author of a paper on the work. “However, we’ve been able to use the reflective nature of air pockets in the lung to calculate the amount of fluid in the lung.”
When ultrasound waves travel through the body, most of each wave’s energy passes through the tissue. But some of that energy is reflected as an echo. By monitoring these echoes, an ultrasound scanner is able to create an image of the tissue that the waves passed through. All of this happens in microseconds.
But when ultrasound waves hit air, all of the energy is reflected – which is why ultrasound images of the lung tend to look like a big, grey blob, with little useful information for healthcare providers. And while there are some techniques that allow users to determine if a patient has pulmonary edema, those techniques still can’t tell how much fluid there is.
This is where Muller’s team comes in.
When ultrasound waves hit air pockets in the lung, or alveoli, they scatter. Those scattered waves hit other air pockets, scattering them further. This process of bouncing around means that it takes an ultrasound’s echo much longer to bounce back to the ultrasound machine – though it’s still measured in microseconds. And that is why the lung looks like a grey blob to the ultrasound scanner.
But no two ultrasound waves take the same path – they may bounce in different directions as they travel through the lung. So their echoes take different amounts of time to return to the scanner. By looking at all of the echoes, and how those echoes change over time, Muller and her collaborators were able to calculate the extent to which the space between the air pockets was filled with fluid.
To test their approach, the researchers conducted two sets of experiments using rats and rat lung tissue.
In the first set of experiments, researchers used rat lung tissue that had been injected with saline solution to mimic fluid-filled lung tissue. The new approach allowed researchers to quantify the amount of fluid in the lung to within one milliliter.
In the second set of experiments, researchers found significant differences between fluid-filled and healthy lungs in rats. Specifically, the researchers were calculating the mean distance between two “scattering events” – or how far an ultrasound wave travelled between two air pockets.
For fluid-filled lungs, the mean distance was 1,040 micrometers, whereas the mean distance in healthy lungs was only 332 micrometers.
“This is important, because one could potentially track this mean distance value as a way of determining how well pulmonary edema treatment is working,” Muller says.
The technique makes use of conventional ultrasound scanning equipment, though the algorithm used by the researchers would need to be incorporated into the ultrasound software.

North Carolina State Universityhttp://tinyurl.com/ycktwghh 

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:36:442020-08-26 14:36:54New approach uses ultrasound to measure fluid in the lungs

Flexible sensors can detect movement in GI tract

, 26 August 2020/in E-News /by 3wmedia

Researchers at MIT and Brigham and Women’s Hospital have built a flexible sensor that can be rolled up and swallowed. Upon ingestion, the sensor adheres to the stomach wall or intestinal lining, where it can measure the rhythmic contractions of the digestive tract.
Such sensors could help doctors to diagnose gastrointestinal disorders that slow down the passage of food through the digestive tract. They could also be used to detect food pressing on the stomach, helping doctors to monitor food intake by patients being treated for obesity.
The flexible devices are based on piezoelectric materials, which generate a current and voltage when they are mechanically deformed. They also incorporate polymers with elasticity similar to that of human skin, so that they can conform to the skin and stretch when the skin stretches.
In a study the researchers demonstrated that the sensor remains active in the stomachs of pigs for up to two days. The flexibility of the device could offer improved safety over more rigid ingestible devices, the researchers say.
“Having flexibility has the potential to impart significantly improved safety, simply because it makes it easier to transit through the GI tract,” says Giovanni Traverso, a research affiliate at MIT’s Koch Institute for Integrative Cancer Research, a gastroenterologist and biomedical engineer at Brigham and Women’s Hospital, and one of the senior authors of the paper.
Canan Dagdeviren, an assistant professor in MIT’s Media Lab and the director of the Conformable Decoders research group, is the paper’s lead author and one of the corresponding authors. Robert Langer, the David H. Koch Institute Professor and a member of the Koch Institute, is also an author of the paper.
Traverso and colleagues have previously developed ingestible devices that can be used to monitor vital signs or deliver drugs to the digestive tract. With the goal of developing a more flexible sensor that might offer improved safety, Traverso teamed up with Dagdeviren, who previously developed flexible electronic devices such as a wearable blood pressure sensor and flexible mechanical energy harvesters.
To make the new sensor, Dagdeviren first fabricates electronic circuits on a silicon wafer. The circuits contain two electrodes: a gold electrode placed atop a piezoelectric material called PZT, and a platinum electrode on the underside of the PZT. Once the circuit is fabricated, it can be removed from the silicon wafer and printed onto a flexible polymer called polyimide.
The ingestible sensor that the researchers designed for this study is 2 by 2.5 centimeters and can be rolled up and placed in a capsule that dissolves after being swallowed.
In tests in pigs, the sensors successfully adhered to the stomach lining after being delivered endoscopically. Through external cables, the sensors transmitted information about how much voltage the piezoelectrical sensor generated, from which the researchers could calculate how much the stomach wall was moving, as well as distinguish when food or liquid were ingested.
“For the first time, we showed that a flexible, piezoelectric device can stay in the stomach up to two days without any electrical or mechanical degradation,” Dagdeviren says.
This type of sensor could make it easier to diagnose digestive disorders that impair motility of the digestive tract, which can result in difficulty swallowing, nausea, gas, or constipation.
Doctors could also use it to help measure the food intake of patients being treated for obesity. “Having a window into what an individual is actually ingesting at home is helpful, because sometimes it’s difficult for patients to really benchmark themselves and know how much is being consumed,” Traverso says.
In future versions of the device, the researchers plan to harvest some of the energy generated by the piezoelectric material to power other features, including additional sensors and wireless transmitters. Such devices would not require a battery, further improving their potential safety.

MIT
news.mit.edu/2017/flexible-sensors-can-detect-movement-gi-tract-1010

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:36:442020-08-26 14:36:58Flexible sensors can detect movement in GI tract

One in three former ICU patients show symptoms of depression, study finds

, 26 August 2020/in E-News /by 3wmedia

An analysis of reports on more than 4,000 patients suggests that nearly one in three people discharged from hospital intensive care units, or ICUs, has clinically important and persistent symptoms of depression, according to researchers at Johns Hopkins Medicine. Symptoms can last for a year or more for some patients and are more likely to occur in people who have a history of psychological distress before an ICU stay, the investigators say.
The prevalence of depressive symptoms in this population is three to four times that of the general population, says study coauthor O. Joseph Bienvenu, associate professor of psychiatry and behavioural sciences at the Johns Hopkins University School of Medicine.
“Not only can people with depression have slower physical recovery, but they also experience financial strain because they often cannot return to work and their caregivers must stay home with them,” Bienvenu says.
Psychological symptoms occurring before an ICU stay and psychological distress experienced during the ICU stay or hospitalization were the risk factors most associated with depressive symptoms after hospital discharge, the review found.
“It’s very clear that ICU survivors have physical, cognitive, and psychological problems that greatly impair their reintegration into society, return to work, and being able to take on previous roles in life,” says senior study author Dale Needham, professor of medicine at JHU’s School of Medicine. “If patients are talking about the ICU being stressful, or they’re having unusual memories or feeling down in the dumps, we should take that seriously,” Needham adds. “Healthcare providers, family members, and caregivers should pay attention to those symptoms and make sure they’re not glossed over.”
More than 5 million patients in the United States are admitted to ICUs each year, Needham says.

John Hopkins Medicine http://tinyurl.com/jnkqmj6

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:36:442020-08-26 14:37:02One in three former ICU patients show symptoms of depression, study finds

ICU patients who survive respiratory condition may suffer from prolonged post-intensive care syndrome

, 26 August 2020/in E-News /by 3wmedia

Patients who survive acute respiratory distress syndrome (ARDS) often leave a hospital intensive care unit with debilitating mental, physical, or cognitive problems that may limit their quality of life.
Now, a new study of 645 ARDS survivors by researchers at Intermountain Medical Center, Johns Hopkins University, and the University of Utah, has identified subgroups of ARDS survivors who suffer what’s been called post-intensive care syndrome, a collection of symptoms that can linger for years.
“A lot of work has been done around post-intensive care syndrome. We’re realizing the people who are surviving are often terribly wounded, and they have emotional and psychological distress as severe as combat veterans returning from war,” said Samuel M. Brown, MD, lead author of the study and director of the Center for Humanizing Critical Care at Intermountain Medical Center. “They may have profound weakness or shortness of breath or other important limitations to their quality of life after they survive.”
ARDS is a potentially life-threatening injury to the lungs that occurs most often in an intensive care unit among critically-ill patients with pneumonia or other infections, although it can have other causes.
For many ARDS patients, the primary symptom is shortness of breath so severe they require lung life-support therapies in order to breathe. ARDS can kill, and older patients are especially vulnerable.
Many ARDS survivors leave the hospital with an array of challenges that form post-intensive care syndrome. The survivors may live with long-term effects, including permanent lung damage and different degrees of physical, cognitive, and mental health problems.
During the last quarter-century, the symptoms of post-intensive care syndrome have been increasingly recognized and understood. Critical care specialists say between half and two-thirds of ARDS survivors struggle with it after they’re released from the hospital, Dr. Brown said.
“Patients are struggling and we’re trying to understand how to guide them through the process of the recovery and develop tailored rehabilitation programs to help them,” he said.
To that end, researchers at Intermountain Medical Center and Johns Hopkins University have been seeking common threads among survivors, focusing on combinations of impairments, including physical health, mental health, and brain function. The study builds on previous research by the team.
In the study of ARDS survivors six months out of intensive care, the researchers found four different patient subgroups:
 

  • those with mildly impaired physical and mental health (22% of patients)
  • those with moderately impaired physical and mental health (39%)
  • those with severely impaired physical health and moderately impaired mental health (15%)
  • those with severe physical and mental health impairments (24%).

 
According to the research, physical and psychological injuries tend to go hand in hand. Cognitive impairment is independent of those two, however.
The study found people who have worse physical problems have worse symptoms of anxiety, depression, or post-traumatic stress disorder. The one exception was a small but distinct group (15% of all survivors) who had severe physical limitations, but only moderately severe mental health problems.
Researchers speculate that could mean those individuals already had some chronic physical challenges before developing ARDS and were more accustomed to living with physical limitations.
“It’s also possible that group might have more resilience, so they’re better able to respond to the new physical disability, which is consistent with other recent studies suggesting that improving resilience may help ARDS survivors,” Dr. Brown said.
The study noted that six months after leaving intensive care, about half of the subjects in the study still weren’t living independently, even though 91 percent of them had done so prior to contracting ARDS. Instead, they lived in nursing homes or with relatives.

Intermountain Healthcare
intermountainhealthcare.org/news/2017/08/icu-patients-who-survive-respiratory-condition-may-have-post-intensive-care-syndrome/

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:36:442020-08-26 14:37:06ICU patients who survive respiratory condition may suffer from prolonged post-intensive care syndrome

Monitor biometrics with sweat, even when the patient is resting and comfortable

, 26 August 2020/in E-News /by 3wmedia

One downside to medical sensors that test human sweat: You have to sweat. Sweating from exertion or a stifling room temperature can be impractical for some patients and unsafe for others. And unless they are on the second leg of the Tour de France, it’s unlikely patients will want to sweat all day for the benefit of a sensor reading.
But researchers at the University of Cincinnati have come up with a novel way to stimulate sweat glands on a small, isolated patch of skin so subjects can stay cool and comfortable and go about their daily routine without spending hours on a treadmill.
UC professor Jason Heikenfeld and UC graduate Zachary Sonner came up with a device the size of a Band-Aid that uses a chemical stimulant to produce sweat, even when the patient is relaxed and cool. The sensors also can predict how much patients sweat, an important factor in understanding the hormones or chemicals the biosensors measure.
"Doctors would love to know if chemical concentrations are increasing or decreasing over time," Heikenfeld said. "What was your baseline before you got sick? Then by measuring the change in concentrations, we know even more about how sick you are or how quickly you are getting better."
Blood analysis is considered the gold standard for biometric analysis. But biometric testing with blood is invasive and often requires the use of a lab. It is far more difficult for doctors to perform continuous monitoring of blood over hours or days.
Sweat provides a non-invasive alternative, with chemical markers that are more useful in monitoring health than saliva or tears, Heikenfeld said.
“People for a long time ignored sweat because, although it can be a higher-quality fluid for biomarkers, you can’t rely on having access to it,” Heikenfeld said. “Our goal was to achieve methods to stimulate sweat whenever needed — or for days.”
Scientists say sweat provides much of the same useful information about patients as blood. The problem has always been getting the same consistent sample as is possible with a standard blood draw, he said.
For the study, the researchers applied sensors and a gel containing carbachol, a chemical used in eyedrops, to their subject’s forearm for 2.5 minutes.
They used three methods to obtain sensor data: the gel and sensors alone and in combination with memory foam padding (to provide better contact between the sensor and the skin) and iontophoresis, an electrical current at 0.2 milliamps that drives a tiny amount of carbachol into the upper layer of the skin and locally stimulates sweat glands but causes no physical sensation or discomfort.
Then they recorded data obtained from the subject’s sweat for 30 minutes using sensors that measured concentrations of sweat electrolytes. Carbachol was effective at inducing sweating under the sensor for as long as five hours. Heikenfeld said a subsequent study successful generated sensor results for several days using this process to stimulate sweat.
They used a pH-sensitive dye to observe the results. The orange dye turned blue when it reacted with sweat. This demonstrated that the sweat glands were stimulated evenly across the sensor area.
“This work represents a significant leap forward in sweat-sensing technology,” the study concluded.

University of Cincinnati
magazine.uc.edu/editors_picks/recent_features/Sweat.html

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:36:442020-08-26 14:37:09Monitor biometrics with sweat, even when the patient is resting and comfortable

Smartphone case offers blood glucose monitoring on the go

, 26 August 2020/in E-News /by 3wmedia

Engineers at the University of California San Diego have developed a smartphone case and app that could make it easier for patients to record and track their blood glucose readings, whether they’re at home or on the go.
Currently, checking blood sugar levels can be a hassle for people with diabetes, especially when they have to pack their glucose monitoring kits around with them every time they leave the house.
“Integrating blood glucose sensing into a smartphone would eliminate the need for patients to carry a separate device,” said Patrick Mercier, a professor of electrical and computer engineering at UC San Diego. “An added benefit is the ability to autonomously store, process and send blood glucose readings from the phone to a care provider or cloud service.”
The device, called GPhone, is a new proof-of-concept portable glucose-sensing system developed by Mercier, nanoengineering professor Joseph Wang, and their colleagues at the UC San Diego Jacobs School of Engineering. Wang and Mercier are the director and co-director, respectively, of the Center for Wearable Sensors at UC San Diego.
GPhone has two main parts. One is a slim, 3D printed case that fits over a smartphone and has a permanent, reusable sensor on one corner. The second part consists of small, one-time use, enzyme-packed pellets that magnetically attach to the sensor. The pellets are housed inside a 3D-printed stylus attached to the side of the smartphone case.
To run a test, the user would first take the stylus and dispense a pellet onto the sensor—this step activates the sensor. The user would then drop a blood sample on top. The sensor measures the blood glucose concentration, then wirelessly transmits the data via Bluetooth to a custom-designed Android app that displays the numbers on the smartphone screen. The test takes about 20 seconds. Afterwards, the used pellet is discarded, deactivating the sensor until the next test. The stylus holds enough pellets for 30 tests before it needs to be refilled. A printed circuit board enables the whole system to run off a smartphone battery.
The pellets contain an enzyme called glucose oxidase that reacts with glucose. This reaction generates an electrical signal that can be measured by the sensor’s electrodes. The greater the signal, the higher the glucose concentration. The team tested the system on different solutions of known glucose concentrations. The results were accurate throughout multiple tests.
A key innovation in this design is the reusable sensor. In previous glucose sensors developed by the team, the enzymes were permanently built-in on top of the electrodes. The problem was that the enzymes wore out after several uses. The sensor would no longer work and had to be completely replaced. Keeping the enzymes in separate pellets resolved this issue.
“This system is versatile and can be easily modified to detect other substances for use in healthcare, environmental and defense applications,” Wang said. The system stores a considerable amount of data so that users can track their readings over long time periods. However, there is a trade-off in price. While the reusable glucose sensor and 3D printed parts are inexpensive, refill pellets may be slightly more costly than test strips in today’s glucose monitoring kits.
Jacobs School of Engineeringhttps://tinyurl.com/y8jy998h

https://interhospi.com/wp-content/uploads/sites/3/2020/06/logo-footer.png 44 200 3wmedia https://interhospi.com/wp-content/uploads/sites/3/2020/06/Component-6-–-1.png 3wmedia2020-08-26 14:36:442020-08-26 14:36:46Smartphone case offers blood glucose monitoring on the go
Page 202 of 240«‹200201202203204›»

Latest issue of International Hospital

April 2024

2 June 2026

DeepHealth achieves multiple regulatory milestones for Neuro, Prostate and LumbarMR

7 January 2026

Gulf Aorta Summit 2026 Returns to Dubai with a Global Lineup of Aortic Experts

17 December 2025

GE HealthCare receives CE mark for 128cm total body PET/CT

Digital edition
All articles Archived issues

Free subscription

View more product news

Get our e-alert

The medical devices information portal connecting healthcare professionals to global vendors

Sign in for our newsletter
  • News
    • Featured Articles
    • Product News
    • E-News
  • Magazine
    • About us
    • Archived issues
    • Media kit
    • Submit Press Release

Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com

PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.

Scroll to top

This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.

Accept settingsHide notification onlyCookie settings

Cookie and Privacy Settings



How we use cookies

We may ask you to place cookies on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience and to customise your relationship with our website.

Click on the different sections for more information. You can also change some of your preferences. Please note that blocking some types of cookies may affect your experience on our websites and the services we can provide.

Essential Website Cookies

These cookies are strictly necessary to provide you with services available through our website and to use some of its features.

Because these cookies are strictly necessary to provide the website, refusing them will affect the functioning of our site. You can always block or delete cookies by changing your browser settings and block all cookies on this website forcibly. But this will always ask you to accept/refuse cookies when you visit our site again.

We fully respect if you want to refuse cookies, but to avoid asking you each time again to kindly allow us to store a cookie for that purpose. You are always free to unsubscribe or other cookies to get a better experience. If you refuse cookies, we will delete all cookies set in our domain.

We provide you with a list of cookies stored on your computer in our domain, so that you can check what we have stored. For security reasons, we cannot display or modify cookies from other domains. You can check these in your browser's security settings.

.

Google Analytics Cookies

These cookies collect information that is used in aggregate form to help us understand how our website is used or how effective our marketing campaigns are, or to help us customise our website and application for you to improve your experience.

If you do not want us to track your visit to our site, you can disable this in your browser here:

.

Other external services

We also use various external services such as Google Webfonts, Google Maps and external video providers. Since these providers may collect personal data such as your IP address, you can block them here. Please note that this may significantly reduce the functionality and appearance of our site. Changes will only be effective once you reload the page

Google Webfont Settings:

Google Maps Settings:

Google reCaptcha settings:

Vimeo and Youtube videos embedding:

.

Privacy Beleid

U kunt meer lezen over onze cookies en privacy-instellingen op onze Privacybeleid-pagina.

Privacy policy
Accept settingsHide notification only

Sign in for our newsletter

Free subscription